SJ
Sanjeev Jain
About Sanjeev Jain
Data last updated:
Sanjeev Jain has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Azafran Innovacion Limited and Dishman It Xellence Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Azafran Innovacion Limited at ₹8.61 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Mar 2020 | 2007 | ₹8.61 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Jul 2018 | 2018 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjeev Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjeev Jain
Sanjeev Jain has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Azafran Innovacion Limited and Dishman It Xellence Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Azafran Innovacion Limited at ₹8.61 Cr (FY 2024).
Sanjeev Jain is associated with 1 company as Director, including Azafran Innovacion Limited (₹8.61 Cr).
Sanjeev Jain has expertise in General Business.
Sanjeev Jain has 8 years in corporate governance.
By reported revenue, the largest current company of Sanjeev Jain is Azafran Innovacion Limited, with revenue of ₹8.61 Cr (FY 2024).
Sanjeev Jain currently holds positions at 1 company: Azafran Innovacion Limited (₹8.61 Cr).